OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
June 08, 2015
In a Citizen Petition to FDA, AbbVie calls the current biosimilar labeling practices “legally unsound.”
June 02, 2015
Successful drug delivery via a dry powder inhaler is determined by the API physicochemical properties, the formulation composition and process, the device and operating conditions, the patient–device relationship, the environmental variables, and ultimately, patient compliance.
Biopharma companies on both sides of the Atlantic ship more of their assay testing to outside service providers.
Pharmaceutical Technology spoke with David Fitzhenry about the costs of specialty drugs.
PAT holds the key to real-time quality assurance and consistent product quality in pharmaceutical manufacturing.
Eppendorf’s Conical screw cap tubes in 15 mL and 50 mL complete a range of volume sizes that meet needs from 0.5 mL to 50 mL.
Will biosimilars share a compendial identity like generic drugs do?
Box-Behnken modeling was used to optimize a resinate complex, to mask the taste of levocetirizine dihydrochloride and montelukast sodium in orally disintegrating tablets.
May 31, 2015
Gyrolab CHO-HCP Kit 1 detects and quantifies host cell proteins from Chinese hamster ovary cells.
May 29, 2015
The draft guidance document clarifies chemistry, manufacturing, and controls information for marketing applications.